SLS
Sellas Life Sciences Group Inc
Mentions (24Hr)
-50.00% Today
Reddit Posts
SLS, ONDS, DRTS and HOVR
Thoughts on HOVR, SLS, DRTS and ONDS
SLS as a Squeeze Candidate - Looking for Feedback
Hot take, looking for opinions.
Linde (LIN): Who's fueling the rocket hype?
Here is what can still fail the SLS trial when success seems "guaranteed"
SLS, NBIS or SNXX for this coming week
Thoughts on my portfolio fairly new to the stock game messed around with the game stop/blockbuster stuff way back when since then I've shifted my focus into making my stocks work for me and I'm still learning so all advice is welcome.
Is SOFI and NOW calls a good idea in the MU, ASTS, SLS, NOK market hype?
Little less than 3 months in and I think I’m doing well
Immunotherapy for AML Remission Maintenance - GPs Phase 3 Results $SLS Now Truly Imminent. 80th Event PR offers as sure a Sure thing there ever was or Will Be in the Market
Immunotherapy for AML Remission Maintenance - GPs Phase 3 Results $SLS Now Truly Imminent. 80th Event PR offers as sure a Sure thing there ever was or Will Be in the Market
Sell some Intel to take a larger position in SLS? I’m OKAY with the greed, but I’m not sure my logic is sound.
Hold Intel vs buying more SLS . I’m leaning greed, but have I’m not sure about my logic.
SLS - up 25% in a day.. Are we seeing a squeeze right now?
Pay Attention to SLS for a potential squeeze
The Distilled 3: Free Weekly Biotech Catalyst Picks (and daily deep dives/updates, written by a PhD patent agent)
The Distilled 3: Free Weekly Biotech Catalyst Picks (and daily deep dives/updates, written by a PhD patent agent)
The secret OS numbers of DRTS in Pancreatic Cancer
Portfolio in the middle of doom and gloom for SaaS.
Three names I’ve been looking at lately — AI energy, oncology trials & US rare earth supply (SES, SLS, USAR)
Biotech feels broken… but that’s usually when things get interesting
5 countries, 5 small-cap copper names I’d watch right now
$SLS (Deepest Due Diligence for SLS-009, Machine Learning Models and Results, and Buyout Deep DD) (From a Deep Value Investor)
What’s a stock you have that you found through Reddit that’s done the best for you?
Thanks dude who posted SLS on WSB a month or so ago.
SLS still shadow banned around here?
First penny stock portfolio looking for feedback. (M) 31
What to do leading up to buyout of stock? (SLS)
$SLS (Deepest Due Diligence for REGAL Trial) (From a Deep Value Investor)
Locked in. I knew SLS was gonna start to take off
$SLS (SELLAS Live Sciences) is turning into a problem for short sellers
SLS: 🔥 The "SECRET" Meetings + Digital Smoke! 🚀
$SLS Part 2 and FINAL (Deepest Due Diligence for REGAL Trial) (From a Deep Value Investor) (Predicting BAT mOS from Predictive Model)
$SLS Part 2 and FINAL (Deepest Due Diligence for REGAL Trial) (From a Deep Value Investor) (Predicting BAT mOS from Predictive Model)
Is $SLS Still Constructive or Losing Momentum?
What I’m Not Buying This Week (Even If It Pops)
Catalyst Ranking: Probability vs Impact
Tuesday Watchlist: Tight Floats, Clinical Reads, and Macro Tension
Do you guys think $SLS really is a big opportunity?
$SLS (Deepest Due Diligence for REGAL Trial) (From a Deep Value Investor)
SELLAS Life Sciences (SLS) - Deep Dive DD on GPS and the REGAL trial
Finally hit $1k at 21 years old. Dm me for investment advice/s
Finally hit $1k at 21 years old. Dm me for investment advice
Gambling the rest of my money on HOOD calls because fuck it
Gambling the rest of my money on HOOD calls because fuck it that’s why
DD: SLS to $100+: The "New Math" Moonshot
SLS is the most popular penny stock right now
$SWAG the swaggiest stock out there!
SLS- First option/stock trade ever am I a certified trader now.
Hopped on when SLS first hit WSB first time I've ever traded,all my savings am I certified regarded?
Reddit Ticker Mentions JAN.22.2026 - $NFLX, $IBRX, $SPY, $ASTS, $GORO, $MSFT, $NVDA, $SLS, $VOO, $RIME
Reddit Ticker Mentions JAN.22.2026 - $NFLX, $IBRX, $SPY, $ASTS, $GORO, $MSFT, $NVDA, $SLS, $VOO, $RIME
My Process for Finding Early Penny Stocks
$SLS Short Interest = 49,429,420 shares, 29.16%
chatGPT, regarding Sellas Life Sciences Group (SLS) and the Phase 3 REGAL Trial, answer the following questions...
chatGPT, regarding Sellas Life Sciences Group (SLS) and the Phase 3 REGAL Trial, answer the following questions...
chatGPT, regarding Sellas Life Sciences Group (SLS) and the Phase 3 REGAL Trial, answer the following questions...
chatGPT: regarding Sellas Life Sciences Group (SLS) and their Phase 3 REGAL Trial, answer the following questions by repeating the questions and following the question with the answers. (precede assumptions with "assuming" and estimates with "about")
How The Hell You Degenerates Pick Stocks?
My top picks for 2026- state your case
Which of these could 10x from TODAY’S prices?
Which of these stocks has the best long term upside at today’s price?
SLS: Black-Scholes provision and warrants
Mentions
So what you buying tomorrow? Check out optx and aeva. You in SLS calls? August is prime. [Don't ask me why]
SLS easily the most promising biotech I have seen
It says you don't have enough SLS.
Sitting on SLS. Happy with the returns. Glad the company is having a positive impact. Hoping they manage the same with the next line.
At a brief glance, SLS, ONDS, and DRTS seem to have gone up a lot in the relative past…there is room for downside. If you are in the green, I would take profits on SLS and DRTS. Both are pharma plays that can be brutal. SLS especially seems to have had a past of big upswings and downtrends. I really like the whole idea of electric VTOL aircraft like HOVR, however I feel like that whole sector is years if not decades away from commercialization and success. If you are in at a good price ONDS seems like the best to hold. But even that seems frisky in this shaky inflated market.
What’s everyone buying on this dip? I am eyeing NBIS, APLD, ONDS, SLS to name a few
When are you expect SLS to go up?
Probably one of the last chances to buy SLS this cheap
Apprecaite that a lot!! but no, CW is the SLS GOAT!
why does the chart show SLS at 4.90? its trading at 7.90
Gonna sell everything I have so it will moon right after. Buy RKLB, NBIS, SLS, HOVR, XOVR, CXAI and XOVR
Can anyone confirm if going full port into $SLS at $8.29 makes me regarded?
Hi your biggest fan from SLS here. You’re comparable to confident web
I have 4.1 thousand dollars of SLS calls and leaps! 😃
One of you has 4.1 million dollars of SLS?
attn mods: The ticker crawl is in error, showing SLS at $4.xx, when it is actually at $8.04 AH
Yeah well what was the assumed cost per kg per launch when those numbers were calculated? Starship I’ve seen estimates from $20-200 per launch kilo to orbit. SLS is over $21,000. I also just googled cost estimates myself and found wildly different estimates, including an estimate for $9bn to mine the moon followed by another estimate of $500m to mine an asteroid, in the same paper. I disagree $2T, but also even $9B could be more than covered by the revenue from the anthropic deal alone for AI compute. But 500M seems laughably small. There’s also ISRU opportunities as well. Not trying to be an Elon apologist, more of a KSP fanatic which is why I’m honking hopium here
Likely adding more SLS, full ported now
Fuck this bot, it’s saying SLS went down to $4.90 in AH Genuinely fuck this stupid bot
I saw all that, I don’t think there will be a squeeze per say, just thinking there will be a lot of shorts under pressure if the news looks good with the EAACI presentation this weekend. I’m just looking for a decent price rise and maybe unload some shares, then put some into BEAM. But as I told you I’m am holding long on this for the most part and would do the same for BEAM. There’s also PCT which may have a better chance for a squeeze at some point, but I am waiting to see if their available shorts decrease. Borrow rate is around 5-6% and SI I think is 28%. Also someone mentioned VIVO and SLS. But VIVO’s business model seems complicated to me. I haven’t looked into either because again I am tied up for the next week.
SLS Kicking cancer in the nuts don’t care about gasoline prices.
It's supposed to be fully, reliably, and rapidly re-usable. What they've done so far is impressive on its own by mere virtue of the fact that rocketry is impressive. In the grander scheme of what they themselves have set as an essential target, they are absolutely no-where. They haven't had a single flight without major issues, especially with the engines, engines that are supposed to survive the rigors of space launch over and over and over with barely any refurbishment. The logic of public relations necessarily being any different for public or privately financed operations does not hold. It makes no sense. If exploding hardware is embarrassing in one domain, it should be embarrassing in the other as well. It's the same failure. Just think about it, seriously; if Spacex has proven it's the better model, why shouldn't it be okay to 'rapidly iterate' under NASA too? Spacex's reputation despite all their explosions survives and thrives because of a very deliberate campaign to (successfully) convince uncritical folks that exploding expensive hardware is good. Heck, it's not even fast because they are way behind schedule. Also, before it inevitably gets brought up. F9's development very superficially seems to resemble this. In actual fact, it was a competent, simple, solidly-capable platform at its core that quickly started delivering on its primary mission. Nobody said landing them was impossible either -- which is another myth spread by fanboys and spacex itself. It's a narrative they themselves repeated over and over until it got accepted as truth. They are also completely different beasts. Success on F9 does not neatly translate over to a much, much, much more ambitious platform. SLS exists. It's a fully capable, proven product. It's price tag means something, even if it is eyewatering. Starship's supposedly cheaper costs are entirely speculative, especially since it could end up like the N1... very real, but also very not real at all because it never fully materialized.
Starship development is coming on pretty well. It's already proved its ability to deploy Starlink satellites into orbit, and they've caught the booster serval times. Bear in mind, they chose a very different design approach to NASA. NASA rockets work first time because public relations are more important than time and money. So they take 4x longer and 10x the budget with their development. SpaceX just cares about fast results, so they take big risks and they fly, fix and fly again. Starship was always going to need 10-15 test flights to work. And it needs a few more test flights yet to demonstrate it can safely deorbit and reenter, but it's not far off that goal, and it'll be ready to fly on the regular in the next 12 months. Also bear in mind, Starship is a pretty cheap rocket compared to what NASA is spending. 20 Starships cost less than a single SLS to build. You can probably tell - I have no love for Elon, and the IPO is a joke, but I fucking love rocketry and I've been following SpaceX for years.
I'm long on SLS and I posted something here and on r/sellaslifesciences a few weeks ago about a potential squeeze. It didn't squeeze majorly, but if you bought when I posted it, you could have sold and made a couple bucks per share in a very short period of time. The big problem is the outstanding warrants that Anson holds (a few weeks ago it was around 25M warrants that Anson could dump or short against). The good news is that preliminary filings have indicated that about half of them were probably exercised during that initial run to 9. There's a lot less ammo to hold it down, and short interest continues to rise. But there are still outstanding warrants, just not nearly enough to cover outstanding short positions. Cost to borrow is rising, but it's hardly expensive. SLS differs from a lot of biotechs in that it is heavily exposed to retail (something like 75% retail, where as most biotechs are about 75% institutional). I think that's a good thing if topline for Regal comes back positive... not so much if the results aren't good, which is what shorts are counting on at this point. With that said, after the initial sell off at 9, a few days later it ran all the way to 9.50, with last week's macro likely being the reason it is currently back at 8.50. That's pretty bullish IMHO. I'd say the odds of a squeeze on this are higher now than what they were a few weeks ago given the way things have played out. There are not nearly enough warrants to cover the outstanding shorts if margin calls start happening. With that said, this stock was less than $2/share not even a year ago. There will come a point when long term holders start trimming their positions and the very least recovering their principal. I wouldn't expect parabolic though. Its market cap is already pretty rich (1.5B) for a biotech that doesn't have FDA approval.
Reddit being so bullish on NBIS and SLS makes me feel like I should sell ASAP.
Widget showing SLS at 4,90 almost gave me a heart attack
BNAI INFQ SLS MI (BNAI strongest potential for weeks bullrun)
I'm 90% in SLS, DRTSW and SIVEF. But SLS about to blow. Should I sell some of the other two to catch this 1-4 month wave? 😰
The mag seven are looking more enticing than ever! We had two down days in months lol it’s gonna happen. I’m not selling anything. In fact I added more Friday afternoon. Everyone overreacted due to multiple events on Friday… Job report, Broadcom earnings, and just being a Friday. Perfect recipe for a huge down day. Back to business this week. Enough of the loss showing. I’m down 12 grand myself Friday alone. It is what it is. I’ll be up 14 by the end of the week. I will continue adding Nvidia Meta and Microsoft. Ooooh… And SLS to the moon.💯
I wish i would have put a whole lot more. But hindsight always 20/20. Got any other suggestions besides SLS lol
My 2 favorite stocks BNAI and SLS
SLS 1-27 calls for generational wealth
is SLS just a Reddit meme pump right now or are people actually expecting the trial to come through?
Huge post-give-a-sht-about-the-war rally profit taking seems normal. Huge run huge friday rotate. My main stocks: SLS up 60% last month DRTSW up 102% last month SIVEF up 32% last month AIRJW up 88% last month. Not too worried. If it bleeds into tuesday I'll get worried.
No wonder SLS/Artemis is so far behind schedule
What’s your cost basis on SLS? Any thoughts when we see 80th event? And how high it can go?
Been investing in DRTSW and SLS since January. Having a good week. I'd love to hear more of your thoughts and picks man. I think many of us would. Please post here or somewhere.
Sure glad I'm all in on SLS, DRTSW and SIVEF! How'd you guys do this week?
That's like me and SLS . Good luck 👍🏻
Thats from when SLS was a ticker for a company called galena, Sellas life sciences acquired the ticker after a reverse merger in 2017
I know and have been around biostocks. I'm trying to save newbies who don't even know that if they fail their primary endpoint that the stock falls so fast that 1. The stop loss doesn't even trigger 2. it will AT LEAST be down 80%. ATYR subreddit is very similar to what the SLS reddit is right now. Look at their reactions now. I'm not celebrating their loss, and I feel bad, but there are lot of selfish pumpers that you will see pumping this in other reddit pages.
It could happen. I sold out my SLS. Risk and reward. Sure it could run out at up but at $9 the reward to sell and lock In gains is greater than the risk. I think for its risk level it’s worth around $6 now. I will not be buying in at current level
Anyone remember ATYR? This is what is gonna happen to SLS. Read the comments: [https://www.reddit.com/r/ATYR\_Alpha/comments/1nhjajw/atyr\_trading\_halted/](https://www.reddit.com/r/ATYR_Alpha/comments/1nhjajw/atyr_trading_halted/)
SLS. Calls are expensive, shares are not
SLS will have a buyout by the end of summer. $40 expected.
Ive been buying the last 3 SLS dips it’s gotta go up at some point
Holding SLS for the BO!!!! 80th event soon!
SLS, all in on the dip at open tomorrow
I asked the same question: “Today looks like a broad risk-off pullback hitting exactly the kinds of names you’re heavy in: AI infrastructure, speculative biotech, small caps, and momentum growth. The main drivers today appear to be: 1. AI valuation / spending fears 2. Rising concern that the market is too concentrated in tech 3. Profit-taking after a huge AI-led run 4. Oil/geopolitical pressure and rate sensitivity 5. Weak breadth under the surface A major catalyst was Alphabet announcing an enormous $80B equity raise to fund AI infrastructure expansion. Markets interpreted that as: * AI is becoming massively capital intensive * dilution risk is real * even the giants need huge funding now That spooked the entire AI ecosystem. At the same time, analysts are warning the market has become dangerously dependent on a handful of AI leaders. Reuters noted tech now represents over 39% of the S&P 500 market cap — above dot-com era concentration levels. That matters for you specifically because many of your holdings sit in: * AI semis * AI infrastructure * robotics * speculative biotech * high-beta growth * moonshots Those sectors tend to get hit hardest when: * yields rise * oil spikes * AI sentiment cools * institutions reduce risk exposure So holdings like: * NVIDIA * Micron Technology * Himax Technologies * Recursion Pharmaceuticals * SLS * MDAI * AST SpaceMobile * Rocket Lab * Symbotic …can easily fall 5–15% in a normal “AI unwind” day even without company-specific bad news. What’s important: This does NOT currently look like a systemic collapse day. It looks more like: * rotation * de-risking * valuation compression * momentum unwinding”
Remember when everyone was talking about SLS non stop? Whatever happened to that?
What about SLS having 107 million cash?
Nah fuck SPCE and SPCX - I am looking at SLS.
I've made my case in the SLS sub. Bottom line is that it will come down to how the events are distributed with the final 20 events. If BAT continues to deteriorate as expected then it will succeed. If it doesn't, it may fail. You don't know. If the remaining 20 couldn't change things, then the trial would have been halted for efficacy. There needs to be enough BAT patients in the final 20 to get the HR ratio needed for the study to succeed. Phase 3 trials fail more than they succeed. Confident web (poster on the SLS sub who is predicting 99%+ chance of success) uses an assumed leakage when he runs his numbers, and you can't assume the leak. It's derisked by an interim analysis that said the study was on track at 60 events. However, 80 events is the target end, and those last 20 matter.
Plus add the 2-3 months of lead time (because some patients weren’t randomized into treatment until 6 months after they achieved CR2—you can go read the DD on that point on the SLS sub). Suddenly you’re at 13-14. I think it probably ends up around there, maybe a touch higher (e.g. 15)
Is SLS a good move? I see it mentioned a lot
I don’t think it does, because for all we know the IDMC did recommend a halt and SLS declined it because they wanted the full data for the trial. Keep in mind that SLS is looking at other indications in AML and other cancers, an early halt and approval for just CR2 does little for their plans.
SLS 1/15/27 calls for imminent 80th event announcement (end of promising clinical trial). It’ll pump on the announcement
What did the demons say about SLS?
SLS, HOVR, CXAI all trending up today just waiting for the breakout
SLS said poof to all Those gains the past week
I stopped the bleeding early on SLS but holy hell
I have a stats background, and I have about 3500 shares of SLS. I'd put the odds of a successful trial around 75% personally, which is as good as any for a binary event. Plus, it's generally believed the company will pursue a buyout if Regal is successful. The TAM for CR1 and CR2 is probably close to 5B with the TAM for CR2 only being in the 1-2B range. The drug itself targets WT1, which is present in about 20 cancers, and they have another drug treating AML on an accelerated pathway with the FDA. Conservatively, a BO would be in the 10-12B range. The trial was derisked via interim analysis at 60 events. That means BAT (best available treatment) mOS (median overall expectancy) was established at that time and can only go down. There are 63 patients in each arm, and to achieve mOS, you need at least 32 events. A 30/30 split means an overperforming BAT group and the trial would have been killed. The trial also has lasted more than a year longer than expected. It means patients are living longer, which generally favors GPS since the BAT arm would already be in the right tail. While SLS is blinded to the data, they have had to publicly change guidance for patients using GPS 3+ years which again is a bullish indicator. My 2 cents. The 80th event will be announced in the next couple months with topline following about a month after that. I would strongly consider some straddles once the 80th is announced. The stock likely rockets in one direction or another at that point. Nothing wrong with some shares, but that's probably a bit riskier now than what it was when I bought in last year. Straddles is the play for easy money. It's also worth noting that unlike most late stage biotechs, it is primarily retail owned and also heavily shorted.
I see a lot of people are butthurt by biostocks in general in those comments. I’m an investor in SLS and that is the only stock I hold. I did my own DD. Looked at others DD. To me the biology looks solid. The company cash position is solid. The platform potential is excellent. Short sellers not understanding the science behind GPS try to capitalize on non-responders and get bent over hard when I mention epitope spreading. I’m pretty confident that Sellas will be succesful in this trial - worst case scenario the hazard ratio will narrowly miss but even in that case, the fact there is no toxicity and GPS can be given ad infinitum is already a valuable business case. PS : I don’t hold a degree, I’m retarded but much less than 99% of mankind. That is all, we’ll see this month or July at readout who got it right on this gamble.
You literally stole the 16.2 mos model from the same source aka CW from SLS sub, you are discrediting here, made some grade 2 dumb chart and some word salad garbage and trying hard to fit in here.
Kicking myself for selling NBIS and DRAM, I’ll sell my CXAI, HOVR and SLS next if you want the next thing to blow up
SLS tmmr pls I need these calls to print
SLS is my hold until 80th
My KEEL avg cost is $1.48 and my SLS avg cost is $1.58 😁 they’re now trading at $6.10 and $9.20 🤑
Buying SLS stock and BTBT January calls. Debating buying SLS calls but not sure yet. KEEL is another one I’m buying shares I think the window for calls has passed.
To be up 700k in most stocks you have to be dumping a ton of money into it as well. Imagine dumping $5-10k into a stock right now based on some research. Would make me spew. Now imagine it being down to only $1k. When I make trades I take profit at $20-50 if it's up that week. For example I'm up $22 on HIMS. I set a Stop Limit to guarantee those profits. $20 a day is $100/week is an extra $5k for the year. But I'm happy with $4k extra. However, I'm up to my balls in SLS back when it was sub $3. It's my dumbest play so far but if I lose the $3k in it, I'm okay with that kind of loss. On the upside I'll take profits on the way up and dump into VTI. I can vouch for SLS more than I can some rockets.
SLS is the biggest play right now, $90 plus by year end min
DRAM RDDT NOW CRSR SLS NFLX let's go
SLS - There has not been a cancer drug study with this particular population (2nd remission, transplant ineligible) where the median mOS was over 11 months (a couple drugs being used in the BAR arm). The last patient in this study was enrolled April 2024. The hype around this stock seems legit, I think this drug could be ground breaking looking at their phase 2 data results, and the timeline of this phase 3 study, which SLS thought would hit 80 events by the end of 2025
NBIS is up about 4.5% over the weekend. SLS is down .6%. SNXX is up about 4%. Memory continues to run
Last week was another gift to your retirement plan or yolo options and I’ve been kicking myself. Only decent score I got was NOW for a 7 bagger. No continuation on ONDS Friday fizzled out the other position. RDDT, HOOD, PLTR, SPCE all rocketing into the end of the week plus more. The weekly 10 bagger streak is over, RUM, SLS, RGTI but the dice rolls continue in this market. Stay alert people!
SLS and SPCE. Some guy copying me
SNXX, KORU, MUU it's screaming in our faces. SLS calls three months out, sell on the 80th event rally. FIX and VG will probably climb steadily all year. My DRTSW warrants up 175% in a month. AIRJW doing good too.
SPCE and sold my calls Friday after doubling my money on calls within a fucking hour. Before that I played the run up to NVDA earnings but sold way too soon. Currently in on SLS. However for lifetime P&L I am down about 90% 😅
Life hack to fast-forward to your goal: Just buy SLS and hold till august. No options, just shares.
I am also into SLS. We will see what happens.
Let’s say you have ONDS, POET, and NBIS. Which one? I’m up 97% on SLS, going to take initial investment back Monday and let it run into one of the 3 Monday.